McKesson EBITDA 2010-2024 | MCK

McKesson EBITDA for the quarter ending September 30, 2024 was $0.741B, a 33.12% decline year-over-year.

  • McKesson 2024 EBITDA was 4.544B, a 8.92% decline from 2023.
  • McKesson 2023 EBITDA was 4.989B, a 78.31% increase from 2022.
  • McKesson 2022 EBITDA was 2.798B, a 171.54% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

McKesson EBITDA 2010-2024 | MCK

  • McKesson 2024 EBITDA was 4.544B, a 8.92% decline from 2023.
  • McKesson 2023 EBITDA was 4.989B, a 78.31% increase from 2022.
  • McKesson 2022 EBITDA was 2.798B, a 171.54% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Labcorp (LH)$19.8B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M